10.1016/S0002-8223(98)00123-0 9597027 View PDFView articleView in ScopusGoogle Scholar 11 D.N. Kerner, T.L. Patterson, I. Grant, R.M. Kaplan Validity of the quality of wellbeing scale for patients with Alzheimer's disease J Aging Health, 10 (1) (1998), pp. 44-61 10.1177/089826439...
In another embodiment, the lipoprotein abnormality is associated with cardiovascular disease, peripheral vascular disease, dyslipidemia, dyslipoproteinemia, restenosis, a disorder of glucose metabolism, Alzheimer's Disease, Syndrome X, a peroxisome proliferator activated receptor-associated disorder, septicemia,...
It has been suggested that discovering treatments for cancer, heart disease, diabetes, and Alzheimer’s disease would be the modern-day equivalent of his accomplishments. In addition to Pasteur’s remarkable achievements, he contributed to the germ theory of disease by popularizing the idea that ...
In neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease, the ratio between GSH and GSSG is considerably reduced [10]. The altercation in the ratio of GSH:GSSG is explored as a potential therapeutic marker to diagnose these neurodegenerative diseases. The role of the ...
significant effects. The executive function enhancement alone did not explain these changes, as there were no significant differences between the experimental groups. It might be that the control task training could also produce some benefits, and multi-component interventions might be useful for weight...